"description","uuid:ID","label","id","name","text","instanceType"
"Main objective","82a7325e-e439-4e00-9c61-f0a639a6e15a","","Objective_1","OBJ1","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","OBJECTIVE"
"Safety","969fca40-974a-4920-9249-bb28d4483086","","Objective_2","OBJ2","To document the safety profile of the xanomeline TTS.","OBJECTIVE"
"Behaviour","c30a3d23-c1a9-48ee-ad0a-770e675fd37d","","Objective_3","OBJ3","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","OBJECTIVE"
